Families of Spinal Muscular Atrophy Awards $710,000 for Basic Research to Identify New and More Effective Approaches for SMA Therapies
28 déc. 2012 10h07 HE
|
Families of SMA
ELK GROVE VILLAGE, Ill., Dec. 28, 2012 (GLOBE NEWSWIRE) -- Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research...
Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; Raises Target Price to $4.50
06 nov. 2012 09h15 HE
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Nov 6, 2012) - Vista Partners announced today that it has updated coverage on ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) ("ADVENTRX" or "ANX"); and raised its...
Repligen Initiates Phase 1b Trial of RG3039 for Spinal Muscular Atrophy Licensed From Families of SMA
26 sept. 2012 16h17 HE
|
Families of SMA
ELK GROVE VILLAGE, Ill., Sept. 26, 2012 (GLOBE NEWSWIRE) -- Repligen Corporation has initiated a Phase 1b clinical study of RG3039, a novel small molecule drug candidate for the potential treatment of...
BCBGMAXAZRIA and ClearVision Optical to Raise Funds and Awareness for Susan G. Komen for the Cure With "Courage"
11 juin 2012 10h07 HE
|
BCBG Max Azria Group
NEW YORK, June 11, 2012 (GLOBE NEWSWIRE) -- For the sixth consecutive year, BCBGMAXAZRIA and its licensee, ClearVision Optical, will partner to create a pair of cause-related, limited edition...
ToonUps Continues to Blend Online Gaming and the Real World
11 avr. 2012 11h08 HE
|
ToonUps
PHILADELPHIA, PA--(Marketwire - Apr 11, 2012) - ToonUps, cause gaming pioneer and creator of A Better World game on Facebook, today announced a campaign with CURE International to send messages...
Facebook Gamers Do 1,000,000 Good Deeds to Help Kids Walk
30 janv. 2012 08h57 HE
|
ToonUps
PHILADELPHIA, PA--(Marketwire - Jan 30, 2012) - ToonUps today announced that they have logged well over one million good deeds in just short of two months in their Facebook game, A Better World....
MIT Enterprise Forum of Cambridge Presents "Defeating Alzheimer's"
30 nov. 2011 08h30 HE
|
MIT Enterprise Forum
CAMBRIDGE, MA--(Marketwire - Nov 30, 2011) - On December 14, 2011 the MIT Enterprise Forum of Cambridge will present an Innovation Series event: "Defeating Alzheimer's." The disease devastates the...
VIRxSYS Issued U.S. Patents for Its Lentiviral Vector and SMaRT RNA Platforms
15 nov. 2011 09h10 HE
|
VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Nov 15, 2011) - VIRxSYS Corporation, a Maryland-based biotechnology company, today announced that the United States Patent and Trademark Office has issued two...
Results From Phase IIB Placebo Controlled Study of Bionor Pharma's Vacc-4x Show Excellent Safety Profile, Statistically Significant Viral Load Reduction in Patients With HIV Who Suspend Antiretroviral Therapy
14 sept. 2011 02h30 HE
|
BionorPharma
BANGKOK, THAILAND--(Marketwire - Sep 14, 2011) - Results from the furthest advanced study of a therapeutic vaccine candidate to treat people living with HIV/AIDS were announced at a news conference...
Bionor Pharma ASA Announces Exploratory Study of Its Lead Therapeutic HIV-Vaccine Candidate Vacc-4x in Combination With Leading Cancer Drug
25 août 2011 08h00 HE
|
BionorPharma
OSLO, NORWAY--(Marketwire - Aug 25, 2011) - Bionor Pharma ASA (OSLO: BIONOR) announces plans to conduct an exploratory clinical study using Bionor Pharma's therapeutic HIV-vaccine candidate,...